FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2081311000001109: Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25038301000001110 Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25038401000001119 Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Is a Aminophylline hydrate 350mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Is pack of Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has active ingredient Aminophylline false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has active ingredient Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has AMP Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has specific active ingredient Aminophylline hydrate true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start